These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 4947152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB.
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunodepressive action of the tumor].
    Belokhvostov AS.
    Vopr Onkol; 1978 Feb; 24(3):99-106. PubMed ID: 347712
    [No Abstract] [Full Text] [Related]

  • 7. The immunology of cancer.
    Angel Basombrío M.
    J Oral Pathol; 1973 Feb; 2(5):231-53. PubMed ID: 4207800
    [No Abstract] [Full Text] [Related]

  • 8. Recent advances in tumor immunology (a review). Is cancer a disease of immune mechanisms?
    Stoloff IL.
    Del Med J; 1971 May; 43(5):121-3. PubMed ID: 5283370
    [No Abstract] [Full Text] [Related]

  • 9. Aspects of immunology in radiotherapy.
    James KW.
    Mod Trends Radiother; 1972 May; 2():77-97. PubMed ID: 4563804
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of immunological enhancement for the growth of autochthonous tumors.
    Hellström I, Hellström KE.
    Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA.
    Schweiz Med Wochenschr; 1971 Apr 03; 101(13):470-4. PubMed ID: 5283773
    [No Abstract] [Full Text] [Related]

  • 13. Lymphocyte sensitivity and cellular immunity in neoplasia.
    Faguet GB, Balcerzak SP, Lobuglio AF.
    Biomedicine; 1973 Feb 10; 19(2):43-7. PubMed ID: 4731978
    [No Abstract] [Full Text] [Related]

  • 14. Humoral cross immunity in patients with malignant tumors.
    Harlozinska A, Albert Z, Richter R, Singer Z, Salwa J.
    Arch Immunol Ther Exp (Warsz); 1971 Feb 10; 19(6):835-49. PubMed ID: 4946994
    [No Abstract] [Full Text] [Related]

  • 15. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF, Wells SA, Herberman RB.
    Surg Gynecol Obstet; 1975 Nov 10; 141(5):779-94. PubMed ID: 128144
    [Abstract] [Full Text] [Related]

  • 16. Tumor-specific cellular immunity.
    Cohen AM, Burdick JF, Ketcham AS.
    J Surg Res; 1971 Aug 10; 11(8):421-31. PubMed ID: 4936302
    [No Abstract] [Full Text] [Related]

  • 17. The immunology of tumors.
    Burk MW, Mckhann CF.
    Surg Annu; 1973 Aug 10; 5():1-29. PubMed ID: 4602210
    [No Abstract] [Full Text] [Related]

  • 18. An overview of cancer immunology.
    Ritts RE, Neel HB.
    Mayo Clin Proc; 1974 Feb 10; 49(2):118-31. PubMed ID: 4591299
    [No Abstract] [Full Text] [Related]

  • 19. Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
    Herberman RB, Hollinshead AC, Alford TC, McCoy JL, Halterman RH, Leventhal BG.
    Natl Cancer Inst Monogr; 1973 Jun 10; 37():189-95. PubMed ID: 4123453
    [No Abstract] [Full Text] [Related]

  • 20. Malignancy as a complication of immunosuppressive therapy.
    Leibowitz S, Schwartz RS.
    Adv Intern Med; 1971 Jun 10; 17():95-123. PubMed ID: 4145004
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.